Diabetes News

Review of the literature and implementation for practical use … Efficacy of CGM systems is now proven but indications, terms of use and educational issues of this new technology still need to be specified (Diabetes Research and Clinical Practice)

This prospective study showed that persons with lower HbA1c had better survival than those with higher HbA1c. The association was linear and independent of disease duration, type of medication use, and presence of co-morbidities. Any improvement of HbA1c appears to be associated with reduced mortality risk (PLoS ONE)

Random UAC >=14mg/l predicted cardiovascular events, diabetic nephropathy, and mortality just as well as ACR. UAC may be used to assess cardiovascular and renal risks in patients with type 2 diabetes (Journal of Diabetes and Its Complications)

This study documents the utility of C-reactive protein in predicting risk for all-cause mortality in European Americans with Type 2 diabetes and supports its use as a screening tool in risk prediction models (Diabetic Medicine)

The MY-Q is the first HRQoL questionnaire designed for use in clinical care. It has acceptable measurement properties and seems suitable for implementation in routine care of teenagers with diabetes (Pediatric Diabetes)

Demonstrating antiatherothrombotic properties of dipeptidyl peptidase-4 inhibitors on proven markers is of substantial clinical significance. Coupled with their proven good safety profile these findings could translate into a significant clinical benefit (Cardiovascular Diabetology)

This study demonstrated that home blood pressure telemonitoring combined with automated self-care support reduced the blood pressure of diabetic patients with uncontrolled systolic hypertension and improved hypertension control (Hypertension)

In 229 adults who met the inclusion criteria, after a mean follow-up period of 31 months, linear regression analysis showed no relationship between eGFR and BMI (Journal of Nephrology)